Encelion LLC v. Polar Electro Oy: Pulse Sensor Patent Dismissed in 91 Days
Encelion LLC, holder of US11471072B2 covering pulse sensor systems and methods, filed an infringement action against Finnish wearable device maker Polar Electro Oy in the Eastern District of Texas. The case closed without a merits ruling after just 91 days, with Encelion voluntarily dismissing without prejudice — leaving the door open for future action.
Early voluntary exit leaves Polar Electro exposure unresolved
On August 26, 2025, Encelion LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Case No. 2:25-cv-00875) against Polar Electro Oy, the Finnish manufacturer known for heart-rate monitoring wearables. The sole patent asserted was US11471072B2, which covers a pulse sensor, system, and method for using a pulse sensor — a technology domain directly central to Polar Electro’s product portfolio.
The case closed on November 25, 2025, when Encelion filed a Notice of Dismissal under Federal Rule of Civil Procedure 41(a)(1)(A)(i), and the Court accepted and acknowledged the notice, dismissing all claims without prejudice. Because the dismissal was entered before the defendant filed an answer or motion for summary judgment, Encelion was entitled to dismiss as of right, requiring no court approval. No monetary award, injunction, or merits ruling was issued.
A 91-day resolution is notably short even by the standards of patent cases that settle early. The without-prejudice designation means Encelion retains the right to refile the same claims against Polar Electro, and the public record does not reveal whether the parties reached a private commercial arrangement, a licensing agreement, or simply that Encelion elected to reassess its litigation strategy. The absence of any cost or fee motion from Polar Electro further limits what can be inferred from the record alone.
Filing to Dismissed without Prejudice in 91 days
91 days — resolved before most E.D. Texas cases reach scheduling order stage
Voluntarily dismissed without prejudice: what the ruling means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, no court permission needed
Under FRCP 41(a)(1)(A)(i), a plaintiff may dismiss an action without a court order by filing a notice before the opposing party serves an answer or a motion for summary judgment. Encelion exercised this right, meaning the Court’s role was ministerial — it accepted and acknowledged the notice rather than adjudicating any dispute. No merits of US11471072B2 were examined.
Procedural exit — no merits rulingWithout prejudice: the critical distinction that keeps claims alive
A dismissal without prejudice does not extinguish Encelion’s patent infringement claims. Encelion may refile against Polar Electro in any competent court, subject to applicable statutes of limitations. A dismissal with prejudice would have permanently barred refiling. The Court’s order is explicit: ‘DISMISSED WITHOUT PREJUDICE.’ The public record does not disclose whether a private settlement, licence, or strategic reassessment drove the decision to exit at this stage.
Refiling remains possiblePolar Electro avoids a merits ruling — but faces continuing exposure
Polar Electro Oy secured a temporary reprieve: no infringement finding, no injunction, and no damages award were entered. However, the without-prejudice dismissal means this is not a final resolution of Encelion’s claims. Polar Electro’s legal and IP teams should treat US11471072B2 as an active risk. No fee award under 35 U.S.C. § 285 (exceptional case) was sought or granted, suggesting the litigation did not escalate to that threshold.
No final clearance obtainedUnresolved pulse sensor IP creates lingering risk for the wearables sector
US11471072B2 covers pulse sensor systems and methods — technology embedded across the wearable fitness and health monitoring market. The case’s early exit without a validity or infringement ruling leaves the patent’s enforceability untested in court. Competitors and OEMs in the wearables space who deploy similar pulse sensing architectures should note that Encelion retains full enforcement rights and may target additional defendants. Freedom-to-operate analysis against this patent remains commercially prudent.
Patent still fully enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Encelion LLC | Company | Patent assertion entity — holder of US11471072B2 covering pulse sensor technologySearch in Eureka ↗ |
| Defendant | Polar Electro Oy | Individual | Polar Electro Oy — Finnish wearable technology company specialising in heart-rate monitorsSearch in Eureka ↗ |
| Plaintiff counsel | Isaac Phillip Rabicoff | Attorney | Counsel for Encelion LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Encelion LLCSearch in Eureka ↗ |
| Defendant counsel | Javan Thomas Porter | Attorney | Counsel for Polar Electro OySearch in Eureka ↗ |
| Defendant law firm | Thompson & Knight LLP – Fort Worth | Law Firm | Representing Polar Electro OySearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The Court’s order tracks the standard language for a Rule 41(a)(1)(A)(i) acceptance: it accepts and acknowledges the notice, formally dismisses all claims without prejudice, and denies remaining relief as moot. The phrasing ‘ACCEPTS AND ACKNOWLEDGES’ confirms the ministerial nature of the act — the Court exercises no discretion and makes no findings on validity, infringement, or claim scope. For Polar Electro, the absence of a with-prejudice qualifier is the operative risk: Encelion’s enforcement rights under US11471072B2 remain fully intact.
US11471072B2 — Pulse Sensor System and Method
US11471072B2 (application no. US17/206065) covers a pulse sensor, the system incorporating that sensor, and the method of using it — a three-pronged claim structure common in medical and consumer biometric device patents. The application number suggests a filing in the 2021 timeframe, placing it squarely within the wave of wearable health monitoring patent activity that expanded during and after the COVID-19 period. The patent’s scope likely encompasses hardware configuration, signal acquisition, and data processing steps associated with pulse detection.
For the wearable technology sector, US11471072B2 represents potential coverage across a wide range of consumer health devices — smartwatches, fitness bands, medical-grade monitors, and hybrid devices. Polar Electro’s core products, including chest-strap and wrist-worn heart-rate monitors, sit squarely within the commercial territory this patent appears designed to address. The untested state of this patent — no IPR, no claim construction ruling — means its effective scope remains uncertain, which itself constitutes a strategic risk for competitors considering design-around or challenge strategies.
Should you run an FTO analysis against US11471072B2?
Any company developing, manufacturing, or distributing wearable pulse sensing devices — including optical PPG sensors, pressure-based pulse detectors, or hybrid biometric wearables — should assess exposure to US11471072B2. The patent’s system-and-method structure means both the device and the software workflow may be implicated. The fact that Encelion filed and withdrew without prejudice in 91 days does not reduce the patent’s enforceability; it may signal that additional defendants are under evaluation.
PatSnap Eureka’s FTO Search Agent can map the independent and dependent claims of US11471072B2 against your product’s technical architecture, surface prior art that could inform an IPR petition, and identify design-around opportunities. Given the breadth of pulse sensor applications and Encelion’s active enforcement posture, proactive FTO work on this patent is commercially prudent for any wearable health tech team before product launch or next-generation development.
Run a freedom-to-operate analysis on US11471072B2 to assess your product’s exposure
Run FTO in Eureka →Similar pulse sensor and wearable biometric patent cases in E.D. Texas
Cases involving wearable pulse sensor and biometric monitoring patents litigated in the Eastern District of Texas, including NPE enforcement patterns and Rule 41 dismissals.
What this case signals for the wearable health sensor IP landscape
A 91-day voluntary exit in E.D. Texas typically signals a shift in litigation strategy, not a final resolution — and pulse sensor IP remains a live enforcement risk.
Without-prejudice exits are not clearances — monitor Encelion’s next move
Encelion’s Rule 41(a)(1)(A)(i) dismissal preserves every option. Companies marketing pulse sensing wearables should track any Encelion refiling activity and assess whether US11471072B2 reads on their specific product implementations before assuming this case closed the issue.
E.D. Texas remains the venue of choice for wearable patent assertions
The Eastern District of Texas continues to attract NPE-led wearable and sensor patent filings. A 91-day case lifecycle is unusually short, suggesting either an early licensing resolution or a strategic pivot. Defendants in this venue face front-loaded legal costs even in cases that never reach claim construction.
Encelion v Polar — key questions answered
A without-prejudice dismissal means the case was closed without any ruling on the merits of Encelion’s infringement claims. Encelion retains the right to refile the same patent claims against Polar Electro or other defendants in the future, subject to applicable statutes of limitations. No findings were made regarding the validity or infringement of US11471072B2.
Encelion asserted US11471072B2, a patent covering a pulse sensor, the system incorporating that sensor, and the method of using a pulse sensor. The corresponding application number is US17/206065. The patent’s claims span device hardware, integrated system architecture, and operational method — a structure that can cover a wide range of wearable biometric products.
The public record does not disclose the reason for the 91-day exit. Possibilities consistent with the record include a private licensing or settlement agreement, a reassessment of infringement or validity positions following early defence counsel engagement, or a strategic decision to refile in a different venue or against different defendants. The absence of a cost or fee motion from Polar Electro limits further inference.
Yes. Because the dismissal was entered without prejudice under FRCP 41(a)(1)(A)(i), Encelion is not barred from refiling claims based on US11471072B2 against Polar Electro or others. The standard six-year patent infringement statute of limitations under 35 U.S.C. § 286 would govern the window for refiling, measured from the date of alleged infringement rather than the dismissal date.
The Eastern District of Texas is a historically plaintiff-favoured venue for patent infringement cases, known for predictable case management and a large body of patent case precedent. NPEs and patent assertion entities frequently file there. While TC Heartland (2017) and subsequent venue decisions constrained some filings, the E.D. Texas retains significant patent docket volume, particularly for technology cases where defendants have established operations or distribution in the district.
PatSnap Eureka searches patents and litigation data to answer instantly.